Overview Single and Multiple Dose Safety, Tolerability, and Pharmacokinetics Study of PF-04805712 in Healthy Volunteers Status: Terminated Trial end date: 2010-08-01 Target enrollment: Participant gender: Summary To assess the safety and tolerability of escalating single and multiple doses of the compound in healthy volunteers Phase: Phase 1 Details Lead Sponsor: Pfizer